RxDoctor Payments Data

Paul Lenkowski

Otolaryngology · Roanoke, VANPI 1497964886

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $180,606 of the $281,523 with a category attached, or 64.2%. Stryker accounts for 73.9% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $81,677, more than ten times the $2,300 reported in 2019. Among otolaryngology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$281,523in general payments, 2019–2025

Across 717 payments — averaging $392.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$208K
  • Optinose US, Inc.$40K
  • Regeneron Healthcare Solutions, Inc.$22K
  • Sanofi$9K
  • GSK$977
  • Kaleo, Inc.$209
  • plus $1K from 17 others

What the payments were for

  • Consulting fees$180,60664%
  • Speaking & faculty fees$61,37122%
  • Travel & lodging$20,9847%
  • Food & beverage$18,1026%
  • Education$4600%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$281,523 in reported general payments places this provider in the 95th percentile of 241 otolaryngology providers in Virginia.

See all otolaryngology providers in Virginia

Medicare billing

Part B allowed, 2024
$1,139,390
Medicare patients
832
Services billed
20,097

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide364$12,440
Azelastine Hcl219$6,672
Epinephrine35$6,070
Fluticasone Propionate388$3,736
Doxycycline Monohydrate267$2,699
Montelukast Sodium235$1,750
Vancomycin Hcl13$1,380
CefuroximeCefuroxime Axetil44$1,317
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$992
Ofloxacin24$852
Omeprazole83$740
Mupirocin101$729
Levofloxacin51$496
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav50$386
Prednisone129$377

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →